R, J., N, S., X, S., R, A., & AG, L. (2017). SR-B1-targeted nanodelivery of anti-cancer agents: A promising new approach to treat triple-negative breast cancer. Dove Medical Press.
Style de citation Chicago (17e éd.)R, Johnson, Sabnis N, Sun X, Ahluwalia R, et Lacko AG. SR-B1-targeted Nanodelivery of Anti-cancer Agents: A Promising New Approach to Treat Triple-negative Breast Cancer. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)R, Johnson, et al. SR-B1-targeted Nanodelivery of Anti-cancer Agents: A Promising New Approach to Treat Triple-negative Breast Cancer. Dove Medical Press, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.